Estrella Immunopharma (ESLAW) Net Income by Year
Estrella Immunopharma reported a net loss of $13.1M in fiscal year 2025. This represents a decrease of 78.7% from the prior fiscal year. The table below carries 5 fiscal years, from 2021 to 2025, and the quarters Estrella Immunopharma has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
ESLAW Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
ESLAW Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More Estrella Immunopharma financials
Frequently Asked Questions
What was Estrella Immunopharma's net income in fiscal year 2025?
Estrella Immunopharma reported a net loss of $13.1M in fiscal year 2025.
How fast is Estrella Immunopharma's net income growing?
Estrella Immunopharma (ESLAW) net income fell by 78.7% year over year, from -$7.3M to -$13.1M in fiscal year 2025.
How has Estrella Immunopharma's net income changed over the years?
Across the 5 fiscal years this page covers, Estrella Immunopharma (ESLAW) net income went from -$248K in fiscal year 2021 to -$13.1M in fiscal year 2025.
What was Estrella Immunopharma's net income in the most recent quarter?
Estrella Immunopharma (ESLAW) reported -$2.3M in net income in Q2 2026. This represents an increase of 58.4% from the same quarter a year earlier.
What does net income mean on a financial statement?
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Estrella Immunopharma (ESLAW) reported on that line in every period on record.